That means 97 percent of the people had an immune response that suggests they could fight off swine flu. [Vaccine maker CSL Biotherapies] also tried the double dose that many people thought would be necessary in another 120 volunteers. The low dose actually worked a bit better — a relief for manufacturers, since the virus that produces the vaccine has been slow to grow in the lab.Of course, H1N1 infections have peaked in some areas, so this is coming a bit late, but it will be helpful in other areas, especially if immunity kicks in earlier (because of the one-time-only dosage) than with other vaccines. It may be too late, of course, for the 2500 believed to have been infected at Washington State University in
Sunday, September 13, 2009
H1N1 vaccine a one-shot deal
Good news on the public health front: Testing has been done for the H1N1 vaccine and it appears that, for healthy adults, only one dose will be needed:
Seattle Pullman since school began in late August.
Meanwhile, South Korea is reporting its sixth death from swine flu, a sixty-seven-year-old man. And I have not found out if Chungnam National University's efforts to produce the H1N1 vaccine have been part of these dosages which are finally being released to the public.